Search
for
Sort by
Research 631–660 of 1000+
- Alopecia Areata
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Primary Cicatricial Alopecias
- A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss
- Chapter 20. Pathogenesis and Treatment of Alopecias
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- Erosive Pustular Dermatosis of the Scalp
- Acquired Hyperpigmentation and Cicatricial Alopecia
- Cronkhite-Canada syndrome: A rare disease presenting with dermatological and gastrointestinal manifestations
- Alopecia areta: a review
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Hashimoto Thyroiditis - A Comprehensive Review
- A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
- Ayurvedic Management of Seborrheic Dermatitis
- Tinea Capitis: A Practical Approach
- Trichotillomania and Traction Alopecia
- ALOPECIA AREATA
- Hair Loss in Women
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Review of systemic methotrexate therapy in pediatric dermatoses
- Satoyoshi syndrome: A rare multisystemic disorder requiring systemic and symptomatic treatment
- Skin manifestations associated with systemic diseases – Part I
- Topical and Systemic Therapies in Melasma: A Systematic Review
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report